{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T18:11:33Z","timestamp":1733508693011,"version":"3.30.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods &amp; Clinical Development"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.omtm.2024.101324","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T08:30:00Z","timestamp":1724401800000},"page":"101324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quantification of circulating TCR-engineered T cells targeting a human endogenous retrovirus post-adoptive transfer using nanoplate digital PCR"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4273-2907","authenticated-orcid":false,"given":"Stefan","family":"Barisic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Cherkasova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Nadal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelina","family":"Parrizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert N.","family":"Reger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina M.","family":"Scurti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael I.","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard W.","family":"Childs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2024.101324_bib1","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/stmcls\/sxac021","article-title":"Graft-Versus-Solid-Tumor Effect: From Hematopoietic Stem Cell Transplantation to Adoptive Cell Therapies","volume":"40","author":"Barisic","year":"2022","journal-title":"Stem Cell."},{"key":"10.1016\/j.omtm.2024.101324_bib2","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2024.101324_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1056\/NEJMoa1804980","article-title":"Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma","volume":"380","author":"Schuster","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2024.101324_bib4","doi-asserted-by":"crossref","first-page":"132ra53","DOI":"10.1126\/scitranslmed.3003761","article-title":"Decade-long safety and function of retroviral-modified chimeric antigen receptor T\u00a0cells","volume":"4","author":"Scholler","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2024.101324_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00262-017-2073-0","article-title":"Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T\u00a0cells","volume":"67","author":"Moore","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.omtm.2024.101324_bib6","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s41591-022-01800-8","article-title":"Claudin18.2-specific CAR T\u00a0cells in gastrointestinal cancers: phase 1 trial interim results","volume":"28","author":"Qi","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2024.101324_bib7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-021-04390-6","article-title":"Decade-long leukaemia remissions with persistence of CD4+ CAR T\u00a0cells","volume":"602","author":"Melenhorst","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2024.101324_bib8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fmolb.2020.00084","article-title":"Digital-Droplet PCR for Quantification of CD19-Directed CAR T-Cells","volume":"7","author":"Mika","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.omtm.2024.101324_bib9","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nmeth.2633","article-title":"Absolute quantification by droplet digital PCR versus analog real-time PCR","volume":"10","author":"Hindson","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtm.2024.101324_bib10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jmoldx.2020.02.007","article-title":"Detection and Quantification of Chimeric Antigen Receptor Transgene Copy Number by Droplet Digital PCR versus Real-Time PCR","volume":"22","author":"Lou","year":"2020","journal-title":"J.\u00a0Mol. Diagn."},{"key":"10.1016\/j.omtm.2024.101324_bib11","doi-asserted-by":"crossref","first-page":"306.e1","DOI":"10.1016\/j.jtct.2023.12.672","article-title":"Digital PCR Improves Sensitivity and Quantification in Monitoring CAR-T Cells in B Cell Lymphoma Patients","volume":"30","author":"de la Iglesia-San Sebasti\u00e1n","year":"2024","journal-title":"Transplant. Cell. Ther"},{"key":"10.1016\/j.omtm.2024.101324_bib12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/07388551.2022.2037503","article-title":"Current Commercial dPCR Platforms: Technology and Market Review","volume":"43","author":"Tan","year":"2023","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.omtm.2024.101324_bib13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/hgtb.2016.059","article-title":"Application of Droplet Digital PCR for Estimating Vector Copy Number States in Stem Cell Gene Therapy","volume":"27","author":"Lin","year":"2016","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omtm.2024.101324_bib14","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.omtm.2019.12.018","article-title":"Digital PCR Assays for Precise Quantification of CD19-CAR-T Cells after Treatment with Axicabtagene Ciloleucel","volume":"16","author":"Fehse","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2024.101324_bib15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12967-020-02358-0","article-title":"Application of droplet digital PCR for the detection of vector copy number in clinical CAR\/TCR T\u00a0cell products","volume":"18","author":"Lu","year":"2020","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.omtm.2024.101324_bib17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12967-021-02925-z","article-title":"Droplet digital PCR allows vector copy number assessment and monitoring of experimental CAR T cells in murine xenograft models or approved CD19 CAR T cell-treated patients","volume":"19","author":"Haderbache","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.omtm.2024.101324_bib19","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jmoldx.2023.06.002","article-title":"Validation of a High-Sensitivity Assay for Detection of Chimeric Antigen Receptor T-Cell Vectors Using Low-Partition Digital PCR Technology","volume":"25","author":"Arcila","year":"2023","journal-title":"J.\u00a0Mol. Diagn."},{"key":"10.1016\/j.omtm.2024.101324_bib16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1200\/JCO.2024.42.4_suppl.435","article-title":"Final results of a phase I trial of HERV-E TCR transduced T\u00a0cells for the treatment of HLA-A\u221711 patients with metastatic clear cell renal cell carcinoma (mccRCC)","volume":"42","author":"Nadal","year":"2024","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.omtm.2024.101324_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/mto.2016.9","article-title":"High-content molecular profiling of T-cell therapy in oncology","volume":"3","author":"Novosiadly","year":"2016","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.omtm.2024.101324_bib20","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.omtm.2020.02.003","article-title":"Optimized Assessment of qPCR-Based Vector Copy Numbers as a Safety Parameter for GMP-Grade CAR T Cells and Monitoring of Frequency in Patients","volume":"17","author":"Kunz","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2024.101324_bib21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/2472630317705680","article-title":"Digital Assays Part I: Partitioning Statistics and Digital PCR","volume":"22","author":"Basu","year":"2017","journal-title":"SLAS Technol."},{"key":"10.1016\/j.omtm.2024.101324_bib22","article-title":"Detection of human microchimerism following allogeneic cell transplantation using droplet digital pcr","volume":"2019","author":"Lombard","year":"2019","journal-title":"Stem Cell. Int."},{"key":"10.1016\/j.omtm.2024.101324_bib23","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.3390\/jcm9051457","article-title":"Novel multiplex droplet digital pcr assays to monitor minimal residual disease in chronic myeloid leukemia patients showing atypical bcr-abl1 transcripts","volume":"9","author":"Petiti","year":"2020","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.omtm.2024.101324_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0239819","article-title":"Detection of KRAS mutations in liquid biopsies from metastatic colorectal cancer patients using droplet digital PCR, Idylla, and next generation sequencing","volume":"15","author":"Holm","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2024.101324_bib25","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1182\/blood-2021-153889","article-title":"Detection of Vector Copy Number in Bicistronic CD19xCD22 CAR T Cell Products with Digital PCR","volume":"138","author":"Murphy","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2024.101324_bib26","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1172\/JCI85309","article-title":"CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients","volume":"126","author":"Turtle","year":"2016","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2024.101324_bib27","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/s41591-022-02084-8","article-title":"Whole-body CD8+ T\u00a0cell visualization before and during cancer immunotherapy: a phase 1\/2 trial","volume":"28","author":"Kist de Ruijter","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2024.101324_bib28","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00262-016-1800-2","article-title":"TCR gene-modified T\u00a0cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumors","volume":"65","author":"Spear","year":"2016","journal-title":"Cancer Immunol. Immunother."}],"container-title":["Molecular Therapy - Methods &amp; Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050124001402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050124001402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T17:56:48Z","timestamp":1733507808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050124001402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2329050124001402"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2024.101324","relation":{},"ISSN":["2329-0501"],"issn-type":[{"type":"print","value":"2329-0501"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of circulating TCR-engineered T cells targeting a human endogenous retrovirus post-adoptive transfer using nanoplate digital PCR","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2024.101324","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101324"}}